In line with this, translocations in lymphomas and leukemias occur either in oncogenes active at some stages of B cell maturation (like BCL2, MYC) or in genes orchestrating B cell development and activation (e.g., CD79B, PAX5). The gene discussed is MYC; the disease is lymphoma.